Arcus Biosciences (RCUS) Price & Analysis

Compare

482 Followers

RCUS Stock Chart & Stats

Day’s Range― - ―

52-Week Range$6.50 - $18.98

Previous CloseN/A

Volume107.84K

Average Volume (3M)1.13M

Market Cap

$1.06B

Enterprise Value$1.40B

Total Cash (Recent Filing)$997.00M

Total Debt (Recent Filing)$60.00M

Price to Earnings (P/E)―

Beta1.96

Next Earnings

Jul 31, 2025

EPS Estimate

-1.13

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1.14

Shares Outstanding105,885,140

10 Day Avg. Volume1,081,115

30 Day Avg. Volume1,133,694

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)2.27

Price to Sales (P/S)0.00

P/FCF Ratio3.50

Enterprise Value/Market Cap1.32

Enterprise Value/Revenue1.54

Enterprise Value/Gross Profit10.32

Enterprise Value/Ebitda-1.23

Forecast

1Y Price Target

$27.88

Price Target Upside207.05% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering10

Arcus Biosciences News

PremiumThe Fly

Arcus Biosciences presented data for casdatifan plus cabozantinib

12d ago

RCUS

PremiumCompany Announcements

Arcus Biosciences Holds Annual Stockholders Meeting

20h ago

RCUS

PremiumRatings

Promising Efficacy and Safety of Arcus Biosciences’ Combination Therapy Reinforces Buy Rating

11d ago

RCUS

PremiumCompany Announcements

Arcus Biosciences Presents Promising Phase 1/1b Trial Data

11d ago

RCUS

PremiumRatings

Arcus Biosciences: Promising Results Amidst Uncertainty and Safety Concerns

11d ago

RCUS

PremiumCompany Announcements

Arcus Biosciences’ Earnings Call: Strategic Gains Amid Revenue Challenges

1M ago

RCUS

PremiumThe Fly

Arcus Biosciences price target lowered to $26 from $29 at Wells Fargo

1M ago

RCUS

PremiumRatings

Promising Potential of Arcus Biosciences’ ARC-20 Trial Drives Buy Rating

1M ago

RCUS

See All RCUS News

See All News >

Bulls Say, Bears Say

Bulls Say

Clinical TrialsArcus's combination data at ASCO exceeded expectations, suggesting a stronger future performance for the stock.

Financial PositionArcus ended the quarter with $1 billion in cash, cash equivalents, and marketable securities, which they expect will fund operations through three pivotal readouts.

Therapeutic EffectivenessThe combination of casdatifan and cabozantinib demonstrated synergy in response rates over either agent alone without additive toxicity.

Bears Say

Commercial UncertaintySkepticism has weighed on sentiment due to Gilead's commercial opt-out and overall uncertainty.

Market CompetitionDifficulties competing with established players like Merck and Bristol and the considerable cost of running necessary studies pose challenges.

Prescriber InertiaArcus faces challenges in achieving its vision due to prescriber inertia and strong skepticism towards its PD-1 zimberelimab.

Financials

Income Statement >

Options Prices

Detailed Option Prices >

Ownership Overview

6.46% Insiders

15.23% Mutual Funds

51.34% Other Institutional Investors

11.54% Public Companies and Individual Investors

Detailed Ownership Overview >

RCUS FAQ

What was Arcus Biosciences Inc’s price range in the past 12 months?

Arcus Biosciences Inc lowest stock price was $6.50 and its highest was $18.98 in the past 12 months.

What is Arcus Biosciences Inc’s market cap?

Arcus Biosciences Inc’s market cap is $1.06B.

When is Arcus Biosciences Inc’s upcoming earnings report date?

Arcus Biosciences Inc’s upcoming earnings report date is Jul 31, 2025 which is in 48 days.

How were Arcus Biosciences Inc’s earnings last quarter?

Arcus Biosciences Inc released its earnings results on May 06, 2025. The company reported -$1.14 earnings per share for the quarter, missing the consensus estimate of -$1.031 by -$0.109.

Is Arcus Biosciences Inc overvalued?

According to Wall Street analysts Arcus Biosciences Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Arcus Biosciences Inc pay dividends?

Arcus Biosciences Inc does not currently pay dividends.

What is Arcus Biosciences Inc’s EPS estimate?

Arcus Biosciences Inc’s EPS estimate is -1.13.

How many shares outstanding does Arcus Biosciences Inc have?

Arcus Biosciences Inc has 105,885,140 shares outstanding.

What happened to Arcus Biosciences Inc’s price movement after its last earnings report?

Arcus Biosciences Inc reported an EPS of -$1.14 in its last earnings report, missing expectations of -$1.031. Following the earnings report the stock price went down -1.355%.

Which hedge fund is a major shareholder of Arcus Biosciences Inc?

Currently, no hedge funds are holding shares in RCUS

Arcus Biosciences Stock Smart Score

Neutral

Fundamentals

Return on Equity

-63.17%

Trailing 12-Months

Asset Growth

-10.60%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Arcus Biosciences Inc

Arcus Biosciences (RCUS) is a biopharmaceutical company focused on creating innovative cancer immunotherapies. Headquartered in Hayward, California, the company specializes in the development and commercialization of novel combination therapies aimed at treating cancer more effectively. Arcus leverages its robust drug discovery and development capabilities to advance a pipeline of proprietary and partnered therapeutic candidates targeting a range of cancer types.

RCUS Company Deck

RCUS Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

Arcus Biosciences demonstrated strong financial management and strategic advancements in their casdatifan program, with promising data and collaborations. However, there are concerns about pipeline reprioritization, particularly in the TIGIT program, and a decline in quarterly revenue.Read More>

RCUS Stock 12 Month Forecast

Average Price Target

$27.88

▲(207.05%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"$6","47":"$47","16.25":"$16.25","26.5":"$26.5","36.75":"$36.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":46,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$46.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27.88,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$27.88</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$12.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,16.25,26.5,36.75,47],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.22,12.04923076923077,14.87846153846154,17.70769230769231,20.536923076923078,23.366153846153846,26.19538461538462,29.024615384615387,31.853846153846156,34.683076923076925,37.512307692307694,40.34153846153846,43.17076923076923,{"y":46,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.22,10.655384615384616,12.090769230769231,13.526153846153846,14.96153846153846,16.396923076923077,17.83230769230769,19.267692307692307,20.70307692307692,22.138461538461534,23.57384615384615,25.00923076923077,26.444615384615382,{"y":27.88,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.22,9.433846153846154,9.647692307692308,9.861538461538462,10.075384615384616,10.28923076923077,10.503076923076923,10.716923076923077,10.930769230769231,11.144615384615385,11.358461538461539,11.572307692307692,11.786153846153846,{"y":12,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":15.5,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.07,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.3,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.71,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.12,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.42,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.5,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.89,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.9,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.89,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.71,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.62,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.22,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >